Literature DB >> 11463032

Pamidronate for bone pain from osteolytic lesions in Langerhans'-cell histiocytosis.

K Arzoo, S Sadeghi, V Pullarkat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11463032     DOI： 10.1056/NEJM200107193450318

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

1.  Distinctive growth pattern in a patient with a delayed diagnosis of Langerhans' cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Gregory A Kaltsas; Georgios Delimpasis; Ludwig Wilkens; George Kanakis; Polyzois Makras
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

2.  Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series.

Authors:  Shanthi Sivendran; Harold Harvey; Allan Lipton; Joseph Drabick
Journal:  Int J Hematol       Date:  2011-04-26       Impact factor: 2.490

3.  Langerhans Cell Histiocytosis of the Temporal Bone with Otic Capsule Involvement.

Authors:  J M Blumberg; A Malhotra; X Wu; R K Virk; J F Kveton; E M Michaelides
Journal:  Clin Neuroradiol       Date:  2015-09-04       Impact factor: 3.649

Review 4.  Multisystem Langerhans cell histiocytosis in children: current treatment and future directions.

Authors:  Milen Minkov
Journal:  Paediatr Drugs       Date:  2011-04-01       Impact factor: 3.022

5.  Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis.

Authors:  Liliana Montella; Carmela Merola; Geraldina Merola; Luigi Petillo; Giovannella Palmieri
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

6.  An open-label, prospective, observational study of the efficacy of bisphosphonate therapy for painful osteoid osteoma.

Authors:  Valérie Bousson; Tifenn Leturcq; Hang-Korng Ea; Olivier Hauger; Nadia Mehsen-Cetre; Bassam Hamzé; Caroline Parlier-Cuau; Jean-Denis Laredo; Thierry Schaeverbeke; Philippe Orcel
Journal:  Eur Radiol       Date:  2017-09-07       Impact factor: 5.315

Review 7.  Langerhans cell histiocytosis.

Authors:  Joan Manel Gasent Blesa; Vicente Alberola Candel; Carlos Solano Vercet; Juan Laforga Canales; Christof Semler; Maria Rosa Pérez Antolí; Carlos Rodríguez-Galindo
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.340

8.  Bisphosphonates in Langerhans Cell Histiocytosis: An International Retrospective Case Series.

Authors:  Deepak Chellapandian; Polyzois Makras; Gregory Kaltsas; Cor van den Bos; Lamia Naccache; Raajit Rampal; Anne-Sophie Carret; Sheila Weitzman; R Maarten Egeler; Oussama Abla
Journal:  Mediterr J Hematol Infect Dis       Date:  2016-07-01       Impact factor: 2.576

Review 9.  Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies.

Authors:  Caroline Hutter; Milen Minkov
Journal:  Immunotargets Ther       Date:  2016-10-12

Review 10.  Bone metabolism in Langerhans cell histiocytosis.

Authors:  Athanasios D Anastasilakis; Marina Tsoli; Gregory Kaltsas; Polyzois Makras
Journal:  Endocr Connect       Date:  2018-07-02       Impact factor: 3.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.